Skip to main content
Hebei Changshan Biochemical Pharmaceutical Co., Ltd. (SHE:300255)
China flag China · Delayed Price · Currency is CNY
66.96
-0.65 (-0.96%)
At close: Dec 5, 2025

SHE:300255 Ratios and Metrics

Millions CNY. Fiscal year is Jan - Dec.
Fiscal Year
 CurrentFY 2024 FY 2023 FY 2022 FY 2021 FY 2020 2019 - 2015
Period Ending
 Dec '25 Dec '24 Dec '23 Jan '23 Jan '22 Dec '20 2019 - 2015
Market Capitalization
61,54018,37211,9575,0367,4725,693
Upgrade
Market Cap Growth
198.93%53.65%137.41%-32.59%31.26%11.92%
Upgrade
Enterprise Value
63,84120,35214,0916,8178,6176,631
Upgrade
Last Close Price
66.9619.9913.015.478.096.15
Upgrade
PE Ratio
---287.5831.9922.52
Upgrade
Forward PE
-12.4412.4412.4412.4412.44
Upgrade
PS Ratio
66.3117.828.482.162.522.41
Upgrade
PB Ratio
41.6211.966.641.652.432.00
Upgrade
P/TBV Ratio
50.7414.658.021.802.682.20
Upgrade
P/OCF Ratio
1276.18326.80354.531611.412602.11-
Upgrade
EV/Sales Ratio
68.7919.749.992.922.902.81
Upgrade
EV/EBITDA Ratio
---41.3322.6815.64
Upgrade
EV/EBIT Ratio
---63.1326.5917.98
Upgrade
EV/FCF Ratio
-438.78-----
Upgrade
Debt / Equity Ratio
1.751.661.320.820.570.47
Upgrade
Debt / EBITDA Ratio
---15.104.583.14
Upgrade
Asset Turnover
0.200.230.270.420.610.56
Upgrade
Inventory Turnover
0.620.620.850.560.600.45
Upgrade
Quick Ratio
0.240.250.290.720.520.67
Upgrade
Current Ratio
0.870.911.192.181.972.12
Upgrade
Return on Equity (ROE)
-18.04%-15.83%-51.43%0.33%7.81%9.01%
Upgrade
Return on Assets (ROA)
-2.57%-2.45%-13.46%1.20%4.15%5.41%
Upgrade
Return on Capital (ROIC)
-2.94%-2.71%-14.74%1.30%4.50%5.94%
Upgrade
Return on Capital Employed (ROCE)
-8.50%-7.70%-42.80%2.50%9.40%11.70%
Upgrade
Earnings Yield
-0.49%-1.36%-10.37%0.35%3.13%4.44%
Upgrade
FCF Yield
-0.24%-1.00%-1.72%-8.50%-4.08%-6.73%
Upgrade
Dividend Yield
---0.09%0.32%-
Upgrade
Payout Ratio
---708.02%26.50%27.08%
Upgrade
Buyback Yield / Dilution
-35.95%-0.58%-4.91%6.27%0.23%0.24%
Upgrade
Total Shareholder Return
-35.95%-0.58%-4.91%6.37%0.55%0.24%
Upgrade
Source: S&P Capital IQ. Standard template. Financial Sources.